Trial intelligence / Profile preview

Intravenous iron plus darbepoetin versus oral iron before cardiac surgery in patients with preoperative anaemia

2011-003695-36Phase 2Completed

Sponsor
Brighton and Sussex University Hospitals NHS Trust
Start
Jul 2012
Modality
Erythropoietins → Hormones & Growth Factors → Recombinant Proteins and Enzymes, Interleukins → Cytokines & Interferons → Recombinant Proteins and Enzymes, Colony Stimulating Factors → Cytokines & Interferons → Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 2, randomised, open-label trial of darbepoetin alfa, ferric derisomaltose and ferrous sulfate in anaemia and iron deficiency anemia (IDA) (2 arms), sponsored by Brighton and Sussex University Hospitals NHS Trust. Started Jul 2012; status: completed.

02

Drugs

darbepoetin alfaferric derisomaltoseferrous sulfate
03

Conditions

anaemiairon deficiency anemia (IDA)

Beyond the preview

Go deeper on 2011-003695-36.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2011-003695-36.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call